These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 485921)

  • 21. Fluorophotometry. III. Streptozocin-treated rats and rats with pancreatectomy.
    Klein R; Wallow II; Ernest JT
    Arch Ophthalmol; 1980 Dec; 98(12):2235-7. PubMed ID: 6449921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular fluorophotometry in the normal- and diabetic monkey.
    Jones CW; Cunha-Vaz JG; Zeimer RC; Rusin MM; Langenberg PW; Vygantas CM; Tso MO; Jonasson O
    Exp Eye Res; 1986 May; 42(5):467-77. PubMed ID: 3720865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of aminoguanidine on the blood-retinal barrier in streptozocin-induced diabetic rats.
    Cho HK; Kozu H; Peyman GA; Parry GJ; Khoobehi B
    Ophthalmic Surg; 1991 Jan; 22(1):44-7. PubMed ID: 1826545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Am J Ophthalmol; 1978 Oct; 86(4):467-73. PubMed ID: 707592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats.
    Bahgat M; Anis HH; Peyman GA; Farahat HG; Parry GJ; Khoobehi B
    Int Ophthalmol; 1991 Sep; 15(5):335-41. PubMed ID: 1835966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats.
    Kernell A; Dahlkvist H; Arnqvist H; Ludvigsson J
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):179-81. PubMed ID: 15835015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
    Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorophotometry. II. Streptozocin-treated guinea pigs.
    Klein R; Engerman RL; Ernest JT
    Arch Ophthalmol; 1980 Dec; 98(12):2233-4. PubMed ID: 7447783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R; Ohrloff C
    Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astemizole reduces blood-retinal barrier leakage in experimental diabetes.
    Hollis TM; Sill HW; Butler C; Campos MJ; Gardner TW
    J Diabetes Complications; 1992; 6(4):230-5. PubMed ID: 1482780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biphasic fluorescence decay in kinetic vitreous fluorophotometry.
    Kayazawa F; Miyake K
    Ann Ophthalmol; 1989 Nov; 21(11):425-8. PubMed ID: 2619153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term kinetic vitreous fluorophotometry.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):561-9. PubMed ID: 1471477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
    Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of early retinal changes in diabetes by vitreous fluorophotometry.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Diabetes; 1979 Jan; 28(1):16-9. PubMed ID: 759246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes.
    Enea NA; Hollis TM; Kern JA; Gardner TW
    Arch Ophthalmol; 1989 Feb; 107(2):270-4. PubMed ID: 2521787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.